Delivery Order SPE2DB20D7059-SPE2DB24FPYP8
Award Date
2/1/24
Potential Completion Date
2/2/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,176,731 units of the RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $1,930.30 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds an...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The award, valued at $35,517.52, has an ultimate completion date of April 1, 2024. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT RABIES VACC W-DILUENTS. The contract has a potential value of $1,930.30 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The $38,606.00 delivery order has a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA to deliver pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RABAVERT rabies vaccine with diluents. The $19,303 contract has a completion date of March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of pharmaceuticals and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The $2,895.45 order has a completion date of March 6, 2024 and was awarded on March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key pharmaceutical supplier to DLA, holding a $999,999,999.00 indefinite delivery contract to deliver a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of RABAVERT rabies vaccine with diluents. The $3,860.60 contract has a performance period through March 25, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $9,651.50 to provide RABAVERT rabies vaccine with diluents. This award is part of Amerisourcebergen's broader contract vehicle with DLA, an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, to deliver a wide range of pharmaceutical products and medical supplies to DLA Troop...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a potential value of $9,651.50 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania....
The Defense Logistics Agency has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a potential value of $27,024.20 and a performance period through March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under a larger indefinite delivery contract...